Investors

Date	Name	Title	Type	Shares Traded	Price Range
Sep 19, 2012	powchik peter	Officer	Automatic Sell	7,177	146.89 - 148.00
Dec 18, 2012	powchik peter	Officer	Automatic Sell	21,269	178.62
Dec 19, 2012	powchik peter	Officer	Automatic Sell	10,356	176.79 - 183.13
Dec 20, 2012	powchik peter	Officer	Automatic Sell	6,623	170.44 - 171.11
Jan 2, 2013	powchik peter	Officer	Automatic Sell	16,414	177.82
Jan 3, 2013	powchik peter	Officer	Automatic Sell	13,586	180.83 - 183.10
Jul 25, 2011	powchik peter	Officer	Automatic Sell	14,023	56.26
Jul 26, 2011	powchik peter	Officer	Automatic Sell	10,977	54.74 - 55.19
Jul 25, 2012	powchik peter	Officer	Automatic Sell	7,981	126.76
Jul 26, 2012	powchik peter	Officer	Automatic Sell	7,019	130.40 - 131.07
Feb 21, 2012	powchik peter	Officer	Automatic Sell	60,612	100.32
Feb 22, 2012	powchik peter	Officer	Automatic Sell	49,254	94.71 - 98.05
Jul 14, 2011	roberts william	Officer	Automatic Sell	110	56.43 - 57.07
Sep 6, 2011	roberts william	Officer	Automatic Sell	23,497	62.76 - 68.41
Sep 7, 2011	roberts william	Officer	Automatic Sell	6,503	67.48 - 70.38
Jan 10, 2012	roberts william	Officer	Automatic Sell	37,852	73.92 - 74.35
Jan 11, 2012	roberts william	Officer	Automatic Sell	22,148	73.99 - 77.05
Aug 23, 2012	roberts william	Officer	Automatic Sell	15,000	144.00
Aug 24, 2012	roberts william	Officer	Automatic Sell	3,500	n/a
Jan 19, 2011	roberts william	Officer	Automatic Sell	1,399	34.61 - 35.42
Showing 161-180 of 627 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.